Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
Wednesday, January 27, 2021BioNTech SE and Shanghai Fosun Pharmaceutical Group Co Ltd announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC Hong Kong the COVID vaccine COMIRNATY based on BioNTechs proprietary mRNA tech...
Menarini obtains European Commission approval for the use of ELZONRIS (tagraxofusp) in the treatment of plasmacetoid blast dendritic cell neoplasm (NCDPB)
Monday, January 25, 2021The Menarini Group a privatelyheld Italian pharmaceutical and diagnostic company announced that it has been granted marketing authorization by the European Commission for ELZONRIS tagraxofusp as a monotherapy for the firstline treatment of adult pati...
Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
Friday, January 22, 2021Servier a global and independent pharmaceutical Group and MiNA Therapeutics the pioneer in RNA activation therapeutics announced today a research partnership to identify and develop small activating RNA saRNA therapies for the treatment of neurologic...
Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film for ALS Treatment
Friday, January 22, 2021Mitsubishi Tanabe Pharma America Inc MTPA and Aquestive Therapeutics Inc announced a licensing and supply deal for the US rights to commercialize EXSERVAN riluzole an oral film formulation of riluzole for the treatment of amyotrophic lateral sclerosi...
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Marburg - Germany and enters into a 5-year strategic agreement with GSK
Thursday, January 21, 2021Nexelis a portfolio company of Ampersand Capital Partners and a leading provider of advanced assay development and laboratory testing services in the infectious oncologic and metabolic diseases fields
T-Cure Bioscience and Immunotech Biopharm Ltd Announce License Agreement for Novel HERV-E T Cell Receptor Therapy
Thursday, January 21, 2021TCure Bioscience Inc a privately held clinicalstage immunooncology company developing the next generation of T cell receptor TCR therapies for patients with solid tumors and Immunotech Biopharm Ltd Immunotech
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Wednesday, January 20, 2021Loxo Oncology at Lilly a research and development group of Eli Lilly and Company and Merus NV a clinicalstage oncology company developing multispecific antibodies today announced a research collaboration and exclusive license agreement that will leve...
Cocrystal Pharma Announces Further Development of Influenza A/B Antiviral Compounds by Merck under Exclusive Worldwide License and Collaboration Agreement
Wednesday, January 20, 2021Cocrystal Pharma Inc a clinicalstage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses SARSCoV virus hepatitis C viruses and noroviruses
TenNor Enters Research Collaboration with Janssen for Potential New Treatments for Nontuberculous Mycobacteria Diseases
Tuesday, January 19, 2021TenNor Therapeutics Limited a clinicalstage biopharmaceutical company dedicated to research and development of differentiated products for the treatment of diseases associated with bacterial infections and dysbioses
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
Tuesday, January 19, 2021Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel AdenoAssociated Virus AAV vectorsleveraging Cure Genetics proprietary VELPTM platform to develop nextgeneration gene therapies
